Drug Database
Back to search

France· FR:60329598

CEFOXITINE SUBSTIPHARM 1 g, poudre pour solution injectable

A cefoxitin product containing céfoxitine sodique, registered in France by SUBSTIPHARM. The same ATC class is registered in 7 of our 19 countries.

ATC J01DC01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCEFOXITINE SUBSTIPHARM 1 g, poudre po…ATCJ01DC01REGISTER NO.FR:60329598PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about céfoxitine sodiqueAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cefoxitin is registered in 7 of 19 countries.

Countries holding a registration under ATC J01DC01 (cefoxitin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose
Search cefoxitin products by name

Cefoxitin · ATC J01DC01

7 / 19 countries

  • Canada
  • Finlandprice
  • Franceprice
  • Norwayprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefoxitin costs, country by country.

Normalised to the WHO defined daily dose (6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Cefoxitin · price per daily dose (6 g)

USD · FX 28 Sept 2026

  • ES Spain$28.55
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CÉFOXITINE SODIQUE
Manufacturer
SUBSTIPHARM
Country
France (FR)
ATC code
J01DC01
ATC class
Cefoxitin
Defined daily dose
6 g, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400957850234
    10 flacon(s) en verre

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

51 interactions on record for cefoxitin.

Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cefoxitin against other medicinesHow interaction checks work

Cefoxitin · interactions on record

51 records

  • 20 moderate
  • 2 minor
  • 29 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefoxitin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefoxitin products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Bulgaria · Цефокситин Тенамид
  • Estonia · Cefoxitin Auxilia
  • Spain · Cefoxitina Ldp-Laboratorios Torlan, Cefoxitina Normon
  • United Kingdom (Northern Ireland) · Cefoxitin, Cefoxitin Aft Pharma Uk
  • Greece · Mefoxil 2 G/Vial, Μεfoxil
  • Italy · Mefoxin
  • Portugal · Atralxitina, Cefoxitina Basi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5f969a5a-65ac-4f22-86a3-e502428b1cd0
GET /v1/drugs/5f969a5a-65ac-4f22-86a3-e502428b1cd0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60329598",
  "date_amm": "2010-09-21",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CÉFOXITINE SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about cefoxitin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console